Chair's Vision Statement and Data-to- Clinic Translational Summary

Chair's Vision Statement and Data-to- Clinic Translational Summary

Which Patients with Advanced CSCC Will Likely Benefit Most from PD1 Checkpoint Inhibition? A Best Practice, Evidence-Supported Roadmap for Dermatology Specialist


Published

December 26, 2018

Created by

CMEducation Resources symposium

Related Presenters

Todd Schlesinger, MD, FAAD

Todd Schlesinger, MD, FAAD

Director, Dermatology and Laser Center of Charleston Clinical Research Center of the Carolinas Clinical Instructor, University at Buffalo Department of Dermatology Assistant Clincal Professor, Medical University of South Carolica Department ...